Digital Sequence Information (DSI)

Statement, June 2021

South Centre Statement to the formal meeting of SBSTTA 24

Agenda Item 3: Post 2020 GBF

Subsidiary bodies of the Convention on Biological Diversity (CBD) are formally meeting to advance the Post 2020 Biodiversity Framework. A dedicated funding mechanism for the CBD and mechanism for technology transfer and capacity building should be part of the framework. Read the SC statement.

(more…)

Policy Brief 90, March 2021

Proposals to Advance the Negotiations of the Post 2020 Biodiversity Framework

By Dr. Viviana Muñoz Tellez

Informal consultations are ongoing in virtual format towards the adoption of a Post-2020 Global Biodiversity Framework by the Conference of the Parties (COP) to the Convention on Biological Diversity (CBD). The Fifteenth meeting of the CBD-COP is scheduled to be held on 11–24 October 2021, in Kunming, China. For negotiations to succeed, the Framework must be ambitious, balanced and achievable, building on past commitments. All three pillars of the CBD must be equally advanced. The Rio principles in particular on common but differentiated responsibilities (CBDR), must be clearly reflected. This policy brief advances proposals towards advancing negotiations on the current zero-draft of the Framework towards realizing the 2050 global vision of living in harmony with nature.

(more…)

SouthViews No. 205, 31 August 2020

Digital Sequence Information (DSI) and national measures: approaches and perspectives

By Jorge Cabrera Medaglia

Digital sequence information (DSI, or genetic sequence data) is an emerging aspect of synthetic biology which involves certain functional genetic sequences being shared by different means. The genetic sequences from plants, animals or micro-organisms could be used to support conservation and sustainable use of biological diversity, to develop and commercialize new products and processes, or for other purposes. The regulation of the use of DSI for both commercial and non-commercial entities may have huge implications for the access and benefit-sharing (ABS) regimen established in the international instruments, ongoing processes and regional and national legislation that implement these conventions. International guidance is needed to promote a coordinated approach to secure fair and equitable sharing of benefits while avoiding a negative impact on the non-commercial benefits arising from the genetic data.

(more…)

0

Your Cart